PRKAA1 and Sepsis: It is exciting to consider the possibility of AMPK as a potential therapeutic target in human sepsis given the numerous pre-clinical studies demonstrating a benefit of AMPK activation and associative studies suggesting a potential benefit of metformin in critical illness.